REFERENCES
- Wiswell TE, Bent RC. Meconium staining and the meconium aspiration syndrome: Unresolved issues. Pediatr Clin North Am 1993; 40: 955–81.
- Moses D, Holm BA, Spitale P, Liu MY, Enhorning G. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991; 164: 477–81.
- Wiswell TE, Foster NH, Slayter MV, Hachey WE. Management of a piglet model of meconium aspiration syndrome with high-frequency or con-ventional ventilation. Am J Dis Child 1992; 146: 1287 —93.
- Wiswell TE, Peabody SS, Davis JM, Slayter MV, Bent RC, Merrit AT. Surfactant therapy and high-frequency jet ventilation in the management of a piglet model of the meconium aspiration syndrome. Pediatr Res 1994; 36: 494–500.
- Extracorporeal Life Support Organization Reg-istry. (ELSO), Ann Arbor, MI. January 1997.
- Stolar CJH, Snedecor SM, Bartlett RH. Extra-corporeal membrane oxygenation and neonatal respiratory failure: Experience from the extra-corporeal life support organization. J Pediatr Surg 1991; 26: 563–71.
- Rourke PP, Come RK, Vacanti JP, Ware JH, Lillehei CW, Parad RB, Epstein MF. Extra-corporeal membrane oxygenation and conven-tional therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study. Pediatrics 1989; 84: 957–65.
- Kinsella JP, Neish SR, Shaffer E Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of newborn. Lancet 1992; 340: 819–20.
- Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818–9.
- Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993; 123: 103–8.
- Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994; 124: 302–8.
- Barefield ES, Karle VA, Philips JB, Carlo WA. Randomized controlled trial of inhaled NO in ECMO candidates. Pediatr Res 1995; 37: 195A.
- Stark AR, Davidson D. Inhaled nitric oxide for persistent pulmonary hypertension of the new-born: Implications and strategy for future "high tech" neonatal clinical trials. Pediatrics 1995; 96: 1147 —51.
- Miller CC, Miller JWR. Pulmonary vascular smooth-muscle regulation: The role of inhaled nitric oxide gas. Respir Care 1992; 37: 1175–82.
- Kinsella JP, Abman SH. Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics 1993; 91: 997–8.
- Barrington KJ, Finer NN, Peliowski A, Etches PC, Andrew JG, Chan WKY. Inhaled nitric oxide improves oxygenation in piglets with meconium aspiration. Pediatr Pumonol 1995; 20: 27–33.
- Putensen C, Rasanen J, Lopez FA, Downs JB. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest 1994; 106: 1563–9.